News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
4basebio launches enzymatic ssDNA platform for gene editing applications
Tuesday, May 12, 2026basebio PLC has launched a highcapacity singlestranded DNA ssDNA platform designed to support the development of gene editing and nucleic acidbased therapies
Rznomics Secures FDA RMAT Designation for Liver Cancer Candidate RZ-001
Monday, May 11, 2026Rznomics has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration for RZ its investigational therapy for hepatocellular carcinoma HCC
Nuclera Introduces Antibody Screening Service for AI-Based Drug Discovery
Monday, May 11, 2026Nuclera has launched a new antibody screening service aimed at supporting AIdriven antibody discovery and helping researchers move more quickly from hit generation to lead selection
Merck Completes Acquisition of Terns Pharmaceuticals
Wednesday, May 06, 2026Merck known as MSD outside the United States and Canada has completed the acquisition of Terns Pharmaceuticals Inc
CS Analytical Announces Major Laboratory Expansion
Tuesday, May 05, 2026CS Analytical Laboratory a cGMP FDAregistered and inspected contract laboratory focused on package and container testing for the pharmaceutical biotechnology and medical device sectors
Teva to Acquire Emalex Biosciences to Strengthen Neuroscience Pipeline
Thursday, April 30, 2026Teva Pharmaceutical Industries has agreed to acquire Emalex Biosciences adding a latestage investigational therapy to its neuroscience pipeline as part of its growth strategy
FDA accepts NDA for zipalertinib to treat advanced NSCLC with EGFR exon 20 insertion mutations
Wednesday, April 29, 2026The US Food and Drug Administration has accepted a New Drug Application NDA for zipalertinib for the treatment of patients with locally advanced or metastatic nonsmall cell lung cancer NSCLC with epidermal growth factor receptor EGFR exon insertion...
Terns Pharmaceuticals receives FDA Breakthrough Therapy Designation for TERN-701 in chronic myeloid leukaemia
Tuesday, April 28, 2026Terns Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to TERN for the treatment of adult patients with Philadelphia chromosomepositive chronic
Frost & Sullivan Identifies 10 Strategic Growth Opportunities Redefining Europe's Life Sciences Sector in 2026 with AI, Biotech, and Biomanufacturing Resilience
Friday, April 24, 2026Frost Sullivan highlights strategic growth opportunities in Europes life sciences sector for emphasizing AI integration biotech advancements and resilient biomanufacturing strategies
Dupixent approved in the U.S. for young children with uncontrolled chronic spontaneous urticaria
Thursday, April 23, 2026Regeneron Pharmaceuticals and Sanofi have received approval from the US Food and Drug Administration for Dupixent dupilumab to treat children aged to years with chronic spontaneous urticaria CSU
